Fluorescent drug gives surgeons visual upgrade with real-time nerve mapping

A new fluorescent drug called Bevonescein is helping surgeons see and avoid nerves during delicate procedures. The drug binds to nerve tissue and glows green under special imaging equipment, potentially reducing the risk of accidental nerve damage. Initial trials have shown promising results, with larger studies now underway to assess its impact on surgical outcomes and potential FDA approval.